1. Introduction {#sec1}
===============

Real or perceived threats at job (i.e. stressors) can activate a network of behavioral, psychological and physical reactions in the individual (i.e. psychophysical strain), collectively known as work-related stress ([@bib28]). This chronic stress condition is a process that occurs when a person has or feels a high job demand having however low job control, thus feeling unable to cope with the requests ([@bib14]). Another means driving this kind of chronic stress is the alteration in the effort-reward balance ([@bib50]), in terms of salary, accomplishment or job perspectives in front of demanding tasks. Work-related chronic stress is an emerging factor in the development of physical and mental illness (such as depression) and many people experience physical and psychological symptoms related to stress ([@bib27], [@bib41]). Accordingly, psychophysical strain is associated with increased sickness absences and reduced job performance ([@bib23], [@bib24]).

The pathophysiological events triggered by prolonged exposure to stress in humans are not completely characterized, but they involve the hypothalamus-pituitary-adrenal (HPA) axis involving stress hormones such as corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH) and glucocorticoids, the sympathetic-adrenal-medullary (SAM) axis as well as the endocrine system ([@bib9], [@bib17], [@bib35]). Besides the above mentioned mechanisms, the recognition that immune alteration is a primary pathophysiological mechanism in chronic stress is one of the major scientific insights of the decade ([@bib44], [@bib47], [@bib48], [@bib17], [@bib49]). Previous studies showed that sympathetic system stimulate inflammatory cytokine production ([@bib37]) which in turn augment glucocorticoid production, that has usually anti-inflammatory effects, but it can be also pro-inflammatory, in some cases ([@bib40]). Inflammation has been hypothesized to be a biomarker of chronic psychophysiological stress, with interleukins 6 (IL-6), interferons (IFNs) and tumor necrosis factors (TNFs) as the most investigated candidates ([@bib32]). In addition, other studies reported a general immune suppression ([@bib7], [@bib18]), highlighting the complexity of interactions between brain and immune system. Chronic stress is known to increase susceptibility to infection and cancer, due to immune suppression, but it may also exacerbate allergic or autoimmune conditions involving a shift in cytokine balance from type-1 to type-2 response, meaning a decrease in cellular immunity in favour of a humoral immunity ([@bib17], [@bib29]). Moreover, the stress response includes alterations in the levels of growth factors and neurotrophins, like the brain-derived neurotrophic factor (BDNF) ([@bib4], [@bib39]). Indeed, decreased BDNF levels are associated with stress-related reduction in dendritic branching and spine density of CA3 neurons ([@bib12]).

Psychophysical strain is usually evaluated by the worker himself (i.e., through self-report questionnaires) or by occupational physicians with the aid of ad-hoc questionnaires, which allow quantitative assessment of specific dimensions of psychophysical strain ([@bib23]). However, in addition to the valuable function of these questionnaires, it would be very useful to include in the assessment also objective biological measures, which are still lacking. In this study, we tested the hypothesis that psychophysical strain may affect blood levels of cytokines, chemokines and growth factors, including BDNF and that these relationships might be stronger in females than in males ([@bib21]). From a psychological standpoint, gender may influence in several ways the stress process. For example, previous research has shown that women, compared to men, may perceive work situations as more stressful, engage more frequently in less adaptive coping strategies (e.g., emotion-focused), and also experience higher levels of psychophysical strain ([@bib11], [@bib20], [@bib54]). From a methodological point of view, we examined the relationship between the severity of different psychophysical strain and blood levels of cytokines, chemokines and growth factors in healthy volunteers working at a hospital. To this aim, we have taken benefit of proteomic analysis using a multiplex immunoassay built on magnetic beads for the quantitation of multiple analytes within a single assay ([@bib58]). Using this technique, we assessed a panel of 48 chemokines, cytokines and growth factors, aiming to test the hypothesis that serum concentrations of pro-inflammatory cytokines and growth factors are upregulated, and immune defense related chemokines and growth factors are decreased in relation to prolonged psychosocial stress ([@bib48]). In addition, we measured the neurotrophin BDNF with an ELISA assay, which we recently validated to be the most reliable among six commercial assays ([@bib43]), and we hypothesized that it could be decreased in relation to chronic work-related stress.

2. Material and methods {#sec2}
=======================

2.1. Participants {#sec2.1}
-----------------

The study, conducted as part of larger project aimed at assessing work-related stress risk, was performed examining a sample of workers in an Italian healthcare organization. Workers were informed beforehand by management and participated voluntarily to the study. Workers completed a self-report questionnaire aimed at determining psychophysical strain. Before the questionnaire was administered, the purpose of the present study was explained by a member of the research team, who emphasized that participants should report only psychophysical symptoms attributable to work-related stressful situations (i.e., not imputable to other stressful life events, such as, for example, providing care for a family member or financial difficulties). The questionnaire was completed by 115 subjects who agreed to participate to a clinical interview followed by a blood sample withdrawal. Then, blood samples were collected and sera isolated as previously described ([@bib43]). Subjects reporting mood and anxiety disorders, neuroendocrine diseases, non-pharmaceutical drug abuse or dependence, according to DSM-IV-TR criteria, were excluded from the enrollment. Therefore, the study sample comprised 115 workers, of which 71.3% were women. Regarding the work position, 16.7% were managers-doctors, 63.3% were doctors or head nurses, 20% were nurses. Most respondents had a permanent contract (95.9%) and were working in the hospital for more than 8 years. All participants gave their written, informed consent, and the study was approved by the local ethics committee according to the recommendations of the Declaration of Helsinki.

2.2. Work-related stress assessment {#sec2.2}
-----------------------------------

Subjects were assessed for psychophysical strain using five scales taken from the Q-BO test, an instrument standardized for the Italian context ([@bib13], [@bib22]). The first part of the questionnaire asked respondents to indicate how often, over the past six months, the psychophysical symptoms (see list below) attributable to work-related stressful events, had appeared or exacerbated. The six psychophysical strain dimensions assessed were: anxiety, emotion (depression-like), gastrointestinal disturbances, cardiac disturbances, ergonomic dysfunction at the workplace. The six point response scale ranged from 1 (never) to 6 (every day). The overall strain score was estimated by averaging the scores of each subscale. Both the self-report version of the questionnaire (the one adopted in this study, see [@bib53]) and the form developed for the administration by the occupational physician ([@bib24]) showed good psychometric properties. Additionally, Cronbach\'s alpha in the present study was 0.80 for the anxiety subscale, 0.80 for emotion (depression-like) symptoms, 0.78 for gastrointestinal disturbances, 0.66 for the cardiac disturbances, and 0.80 for ergonomic dysfunction.

The Q-Bo test consists of various scales, reformulated and reduced in the most recent release to about 200 items (from 350 of the original version) - thanks to an experiment conducted on over 30,000 workers - and with a delivery time of about 1 h. The protocol can be adapted to the different needs of organizations in the various public and private contexts both for modules and for specific constructs as well as social and personal information. In particular, sets of scales integrated with each other are available in function of the different types and sizes of the organizations object of survey. The main test configurations are directed specifically to those areas: Education/Training, Manufacturing, metal working industries, Public Administrations and Public Services, Health Sector, Financial Services/Insurance, Social Services. For the different sectors, in a benchmarking perspective, specific reference samples are available (normative values). The scales were developed based on the most extensive international literature, on the needs created by the Italian legislation and the requirements of European and global organizations working in the field of health and safety at work. Thanks to the adoption of a systemic approach, the multidimensional model is used to detect a broad spectrum of work, organizational and individual factors representing potential sources of risk. In particular, by means of the proposed dimensions, the model aims at assessing behavioural, physiological and psychological stress/strain (with particular reference to burnout). These dimensions are in fact designed in order to take into account factors, such as the quantitative and cognitive workload, the degree of control/autonomy, the social rewards in terms of support from the organization, the professional growth, the organizational equity and justice, and the various forms of conflict including conflicts work/life, person-role, with colleagues, between groups/departments of the same organization, with superiors and co-workers, changes, no clear definition of responsibilities. These elements can have negative consequences for the health of the worker and can cause at the same time a deterioration of corporate performance. Another section of the test is dedicated to the detection of psychological and physical symptoms (such as irritability, depression, feelings of ineffectiveness, gastrointestinal problems, insomnia, cardiac arrhythmia) and behavioural symptoms (such as abuse of alcohol, drugs, smoking) and any other discomfort, symptoms and diseases that can be associated with the risk of work-related stress and therefore constitute additional sources/consequences of the risk. The scales taken from the Qu-Bo test assess symptoms that are known to be stress-related on an epidemiological basis (see for example [@bib41]). Moreover, several standardized self-reported questionnaires in the literature assess similar symptoms or dimensions/subscales (e.g., the Physical Symptoms Inventory, [@bib51]; the Physical Health Questionnaire, [@bib45]). With respect to gastrointestinal and cardiac symptoms, examples of item are "Stomach/abdomen cramps or pain" and "heart pounding without any apparent reason", respectively.

The Q-Bo test also investigates some individual characteristics and resources such as resilience, optimism, sense of efficacy, coping strategy (i.e. mode of behaviour to cope with the difficulties), negative affectivity, tendency to over-commitment and social desirability, in order to assess the validity and reliability of answers to several questions. The test also evaluates the critical variables for the organization such as security measures, air conditioning, lighting, cleanliness and hygiene, pleasantness of the working place.

2.3. Biochemical assessments {#sec2.3}
----------------------------

Blood samples were collected in a resting and fasting state between 9.00 am and 12.00 pm in anticoagulant-free tubes and let them to clot for 1 h at room temperature, then resting for an additional hour of at 4 °C. Serum was collected by centrifugation at 2000 × g for 10 min at 4 °C, aliquot and stored at −80 °C until assayed. Multiple analytes were assessed, as listed in [Table 1](#tbl1){ref-type="table"}. Serum BDNF levels were as previously described ([@bib43]), using the BDNF Rapid™ ELISA kit (Biosensis), based on sandwich technology. Cytokines, chemokines and growth factors were measured taking advantage of the multiplex ELISA technology, employing the Bio-Plex Pro Human xMAP Assay 21-plex and 27-plex (Bio-Rad Laboratories Srl, Milan, Italy) read on a Bio-Plex 200 instrument, according to manufacturer\'s instructions. Reliability of cytokines measurements with this methodology was previously validated ([@bib58]). All samples were assayed in duplicate in adjacent wells.Table 1List of biochemical variables.Table 1CytokinesChemokinesGrowth factors**21-plex (BioRad)**IL-1α; IL-2Rα; IL-3; IL-12 (p40); IL-16; IL-18; IFN-α2; LIF; MIF; SCF; TNF-β; TNFSF10/TRAILCCL27/CTACK; CXCL1/GRO-α; CCL7/MCP-3; CXCL9/MIG; CXCL12/SDF-1α;HGF; CSF1/M-CSF; β-NGF; CLEC11A/SCGF-β**27-plex (BioRad)**IL-1β; IL-1Ra; IL-2; IL-4; IL-5; IL-6; IL-9; IL-10; IL-12 (p70); IL-13; IL-15; IL-17; IFN-γ; TNF-α; CSF2/GM-CSFCXCL8/IL-8; CCL11/Eotaxin; CCL2/MCP-1; CXCL10/IP-10; CCL3/MIP-1α; CCL4/MIP-1β; CCL5/RANTES;IL-7; basic FGF;\
CSF3/G-CSF; PDGF-BB; VEGF**BDNF *Rapid***^TM^**ELISA kit (Biosensis)**//BDNF[^1]

2.4. Statistical analyses {#sec2.4}
-------------------------

To test for possible differences in age and body-mass index (BMI) distributions between female and male population considered in this study, we used the *t*-test for independent samples. To test sex differences in distribution of psychophysical strain scores we used a Mann-Whitney *U* test. In addition, to verify the possible confounding effect of BMI, we performed a partial correlation analysis with the scores of psychophysical strain, after controlling for gender. When biochemical variables had sample values below the lower limit of detection (Out-Of-Range values or OOR); when OOR values were over the 30% of the total sample, the analytes were excluded. When performing univariate analysis, for remaining OOR values we imputed the half of the declared sensitivity value for each analyte, while for Partial Least Square regression analysis all variables having OOR were excluded in order to avoid any distortion in the normalized distribution. The influence of the use of drugs on biochemical variables values was tested performing a Mann-Whitney *U* test. Normality distributions of the independent variables were assessed by Shapiro-Wilks tests and visually inspected by Quantile-Quantile (Q-Q) plot analyses *(not shown)*. Since most of the biochemical variables were not normally distributed we applied log-transformation in order to approximate normality distributions, thus being able to perform both univariate associations and multivariate analysis, with the aim to investigate correlations between biochemical variations and differences in the scores of psychophysical strain. As univariate analyses, we perform partial correlation analyses controlling for gender and BMI to identify association between dependent variables (psychophysical strain scores) and each independent variable (biochemical markers). Since we performed multiple factors assessment on same samples, we chose to not correct for multiple comparisons across the different analytes, because this would enhance the probability of type II errors ([@bib34]). A multivariate analysis was also carried out to take in account for potential correlations within the independent variables. Thus, we performed Partial-Least Square discriminant analysis (PLS) and Variable Importance to the Projection (VIP) scores were estimated, for each independent variable, as the average over three latent factors extracted. VIP scores are estimate of the importance of each variable to the model and values equal to or greater than one can be considered prominent in the given model.

3. Results {#sec3}
==========

3.1. Demographic variables {#sec3.1}
--------------------------

We investigated a possible relationship between the serum levels of cytokines and chemokines, BDNF and other growth factors (listed in [Table 1](#tbl1){ref-type="table"}), with the scores of psychophysical strain in 115 healthcare assistants matching the inclusion criteria for this study. Demographic values (age and BMI) are given in [Table 2](#tbl2){ref-type="table"}. Of note, BMI scores in female were significantly lower than those in male population (*t*-test, t = −4.53, p \< 0.001). Psychophysical strain was assessed using five subscales, namely anxiety, emotion (depression-like), gastrointestinal disturbances, cardiac disturbances, ergonomic dysfunction at the workplace and by an overall psychophysical strain score, defined as the average of the five subscales ([Table 3](#tbl3){ref-type="table"}). In the initial section of the questionnaire respondents were asked to indicate how often, over the past six months, the psychophysical symptoms (see list above) attributable to work-related stressful events, had appeared or exacerbated and to discriminate job versus other non-work related stressors. The first step was to verify if the demographic variables (gender, BMI and age) could account for distribution differences of the scores among the different dimensions of psychophysical strain. Indeed, performing a non-parametric Mann-Whitney U--test to assess differences in scores distribution between gender, we found that female subjects had significantly higher score values than males for all the psychophysical strain dimensions ([Table 4](#tbl4){ref-type="table"}). Regarding the possible confounding effect of BMI on psychophysical strain scores, after controlling for gender in a partial correlation analysis, we found that it negatively correlates with anxiety, gastrointestinal disturbance and the overall strain score in both total (N = 115) and drug-free (N = 89) sample populations (see [Supplementary Table S1](#appsec1){ref-type="sec"}). However, since age did not correlate with any of the psychophysical strain score, even after controlling for gender or BMI *(not shown)*, it was not considered as a possible confounder. For all subsequent analysis we performed corrections for gender and BMI.Table 2Demographics of the whole sample population (N = 115).Table 2NMeanSDMin/MaxPAge, yearsFemale8244.908.3425/600.830Male3345.3010.5225/61  BMI, kg/m^2^Female8122.992.7917.72/33.46\<0.001Male3325.673.4617.63/33.56  NMeanSDMin/MaxPAge, yearsFemale6543.828.2825/600.508Male2442.4210.1625/61BMI, kg/m^2^Female6422.862.8917.72/33.460.005Male2424.903.1017.63/30.32[^2]Table 3Psychosocial strain scores distribution in the whole (N = 115) and drug-free (N = 89) sample population.Table 3AnxietyEmotionGastricCardiacErgonomicsOverall strainN total population115115115115115115Mean/SD2.41/1.041.77/0.802.07/1.011.58/0.852.59/1.132.08/0.81Min/Max1.00/5.401.00/5.001.00/6.001.00/5.001.00/5.401.00/5.16  AnxietyEmotionGastricCardiacErgonomicsOverall strainN Valid (Missing)89 (33)89 (33)89 (33)89 (33)89 (33)89 (33)Mean/SD2.38/1.021.79/0.832.01/1.061.55/0.842.65/1.142.10/0.82Min/Max1.00/5.401.00/5.001.00/6.001.00/5.001.00/5.401.00/5.16[^3]Table 4Gender difference in psychophysical strain scores in the whole (N = 115) and drug-free (N = 89) sample population.Table 4Psychophysical strain totalAnxietyEmotionGastricCardiacErgonomicsOverall strainFemale. N = 82; Mean rank62.8663.4062.5362.1562.5163.68Male. N = 33; Mean rank45.9244.5946.7447.6846.8043.88Z−2.47−2.75−2.31−2.24−2.29−2.88Asymp. Sig. P (2-tailed)**0.0130.0060.0210.0250.0220.004**  Psychophysical strain validAnxietyEmotionGastricCardiacErgonomicsOverall strainFemale. N = 65; Mean rank46.7348.0647.1746.5846.1747.24Male. N = 24; Mean rank40.3136.7139.1340.7141.8338.94Z−1.04−1.85−1.31−1.02−0.70−1.35Asymp. Sig. P (2-tailed)0.2960.0650.1900.3100.4810.179[^4]

3.2. Biochemical variables {#sec3.2}
--------------------------

The pre-analytical stages, consisting in serum samples collection and storage, were performed as described previously ([@bib43]). For the analytical stage, taking advantage of the multiplex technology, we screened 48 analytes among cytokines, chemokines and growth factors; BDNF was assessed using the Biosensis kit, which exploits a classical sandwich ELISA technology (see [Table 1](#tbl1){ref-type="table"}, Materials and Methods). The following analytes (11) were excluded from the dataset because more than 30% of samples were below the lower limit of detection (Out-Of-Range or OOR values): interleukins 2, 15, 1-α, 3, 12p40 (IL-2, IL-15, IL-1α, IL-3, IL-12p40), interferon α2 (IFN-α2), leukemia inhibitory factor (LIF), chemokine C-C motif ligand 7 (CCL7/MCP-3), colony stimulating factor 1 (CSF1/M-CSF), beta nerve-growth factor (β-NGF) and tumor necrosis factor-β (TNF-β). Except for cases showing value below the limit of detection (OOR cases), none of the other cases show significant upward outliers: log transformed, standardized values (centered on mean) were all below three standard deviations. The distribution values of the remaining analytes (38) are listed in [Supplementary Tables S3 and S4](#appsec1){ref-type="sec"}. Because 26 persons out of 115 were using pharmaceutical drugs, we verified if drug assumption had an impact on the analyte levels. Drugs taken by subjects are the most common in Western-country population, specifically: anti-hypertensive/heart protectors (42%), anti-lipemic (32%), thyroid stimulators (levotiroxin, 21%), non-steroid anti-inflammatory drugs (16%), anti-migraine (11%) -- the sum is not 100% because some subjects are taking more than one drug. We tested their effects on cytokines levels comparing the median values between the two populations of drug takers and non-takers. As a result, 21 analytes showed significantly different levels between cases who used drugs and who did not (Mann-Whitney *U* test; see [Supplementary Table S2](#appsec1){ref-type="sec"}). In general, pharmaceutical drugs had a negative influence on analytes level, with the exception of interferon-γ (INF-γ) and chemokines C-C motif ligand 4 and 5 (CCL4/MIP-1β and RANTES, respectively), for which we observed increased median values in drug users.

There was no difference in gender distribution among pharmaceutical drug users (Female/Male, 17/9, χ^2^ = 2.46, P = 0.117) and there was also no significant difference between the scores of psychophysical strain in subjects who use drugs and who do not (Mann-Whitney *U* test; not shown). Given these results, in order to limit this confounder and increase the power of predictors, we decided to exclude all the 26 subjects who used drugs. Distributions of psychophysical strain scores of the remaining 89 cases were basically equal to the previous ones ([Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"} and [S1](#appsec1){ref-type="sec"}). After that, since most of the biological variables were not normally distributed, we log transformed all independent variables (including BMI), attempting to achieve normal distribution. Shapiro-Wilks test for normality not always gave non-significant results, but Q-Q plot analysis displays a good approximation to normal distribution *(not shown*). The following correlation analyses were performed also on non-transformed data (*not shown*) giving similar results, leading us to use the transformed data in order to perform multivariate analysis as well.

3.3. Univariate analysis {#sec3.3}
------------------------

As univariate analysis, we performed partial correlations using the log-transformed biochemical data, controlling for gender and BMI, in order to detect association between each predictors (29 in total) and the dimensions of psychophysical strain. Significant associations were found for a total of seven of the independent variables. Specifically, for anxiety the chemokines C-C motif ligand 2, 5, 11 and 27 (CCL2/MCP-1, CCL5/RANTES, CCL11/Eotaxin, CTACK/CCL27) show a negative Pearson\'s product moment of respectively −0.342, −0.320, −0.304 and −0.301 and the interleukin 6 (IL-6) of −0.223. Similarly, for the gastric disturbance, the partial correlation of CCL2/MCP-1, CCL11/Eotaxin and CTACK/CCL27 was negative and with a Pearson\'s product moment of respectively −0.214, −0.325, −0.235, while for interleukin 17 (IL-17) the association was positive (0.280). For the cardiac item, only the chemokine CTACK/CCL27 was negatively associated (−0.272), while for ergonomics problem, a negative partial correlation was found for CCL5/RANTES and CCL11/Eotaxin (−0.221 and −0.240 respectively) and intriguingly, a positive correlation with BDNF (0.284). For the overall strain, results were similar to those found for the anxiety dimension. In fact, it showed a partial negative correlation with CCL2/MCP-1, CCL5/RANTES, CCL11/Eotaxin, CTACK/CCL27, with a Pearson\'s product moment of respectively −0.263, −0.274, −0.307 and −0.258, but no association with IL-6. All α errors were below 0.05 as reported in detail in [Table 5](#tbl5){ref-type="table"}; for a graphical representation of the partial correlations see [Fig. 1](#fig1){ref-type="fig"}. No association with any of the predictors was found for the Depression-like subscale. To evaluate the chance that multiple comparisons could increase type I errors, we performed correction of the p-value according to the Benjamini-Hochberg (BH) procedure which estimates the false-discovery rate (FDR) based on ranked ascending p-values. Correction was done on the number of test performed n = 38, according to the formula pj = n/j\*pj, where p is the ranked p-value and j is its percentile rank ([@bib42]). Only CCL2/MCP-1 retains a significant association with anxiety. However, when considering n = 7, factors associated with anxiety, gastric and overall strain (indicated as stress) subitems were significant. Corrected p-values are given in [Supplementary Table S5](#appsec1){ref-type="sec"}.Fig. 1Scatter plots showing correlations between the given chemokines (CCL2/MCP-1, CCL11/Eotaxin, CCL27/CTACK, CCL5/RANTES), cytokines (IL-6, IL-17) and growth factor (BDNF) and the items of psychophysical strain. Regression lines, R square and P values are displayed. CCL = chemokine C-C motif ligand; CTACK = cutaneous T-cell-attracting chemokine; MCP = monocyte chemoattractant protein; RANTES = regulated on activation, normal T cell expressed and secreted; BDNF = brain-derived neurotrophic factor; IL = interleukin.Fig. 1Table 5Significant correlation between strain scores and biochemical variables.Table 5Variable IDAnxietyGastricCardiacErgonomicsOverall strainCCL11/Eotaxin (df = 83)−0.304 (**0.005**)−0.325 (**0.002**)−0.240 (**0.027**)−0.307 (**0.004**)CCL27/CTACK (df = 84)−0.301 (**0.005**)−0.235 (**0.029**)−0.272 (**0.011**)−0.258 (**0.017**)CCL2/MCP-1 (df = 83)−0.342 (**0.001**)−0.214 (**0.049**)−0.263 (**0.015**)CCL5/RANTES (df = 83)−0.320 (**0.003**)−0.221 (**0.042**)−0.274 (**0.011**)BDNF (df = 82)0.284 (**0.009**)IL-17 (df = 83)0.280 (**0.010**)IL-6 (df = 83)−0.223 (**0.040**)[^5]

Finally, to determine the contribution of each of the identified markers to the different pshychophysical strain subscales, we analyzed the effect size for the calculated correlation factor r, reported as absolute value. On the basis of the Cohen\'s d values, we found a medium effect size for CCL2/MCP-1, CCL5/RANTES, CCL11/Eotaxin, and CCL27/CTACK on anxiety, for CCL11/Eotaxin on gastric problems and stress in general (overall strain), while the effect of the other factors was small ([Supplementary Table S6](#appsec1){ref-type="sec"}).

3.4. Multivariate analysis {#sec3.4}
--------------------------

Multivariate analysis was also performed to explore association between predictors. More specifically, the partial least square regression procedure (PLS) was identified as the best suited method for this purpose because it is particularly useful when predictor variables are highly correlated or the number of predictors is considerable in respect to the number of cases. This method extracts, at first, several latent factors that explain as much of the covariance as possible between dependent and independent variables and then computes a series of score (Variable Importance to the Projection or VIP) that help to identify predictors that best contribute to the association with the dependent variable. As done before with partial correlation analysis, for PLS we used each subscale of psychophysical strain as dependent variable and cytokines, chemokines, growth factors and the interaction effect between gender and BMI as independent variables. In this analysis, we further eliminated the variables whose OOR were substituted with fixed values and therefore could introduce a bias in the distribution: interleukins 1β, 5, 16, 2 receptor-α (IL-1β, IL-5, IL-16, IL-2Rα, respectively), colony stimulating factor 2 (CSF2/GM-CSF), stem cell factor (SCF), chemokines C-X-C motif ligand 1 and 12 (CXCL1/GRO-α and CXCL12/SDF-1α), and tumor necrosis factor super-family member 10 (TNFSF10/TRAIL). In addition, these variables did not correlate with any of the pshychophysical strain subscales in the univariate analysis. The graphs in [Fig. 2](#fig2){ref-type="fig"} show the contribution of information (VIP) of each variable to anxiety, gastric and cardiac disturbances, ergonomic problems and overall strain. Results essentially replicated the findings obtained with the partial correlation analysis, in which the chemokines CCL2/MCP-1, CCL5/RANTES, CCL27/CTACK, CCL11/Eotaxin, the interleukin IL-6 and IL-17 and the neurotrophin BDNF are the best contributors, since their score is above one. Interestingly, other analytes that were not identified in the partial correlation analysis, showed up with PLS: interleukin 9 (IL-9) for anxiety and cardiac problems, interleukin 18 (IL-18) for ergonomic problems and overall stress and chemokine C-C motif ligand 4 (CCL4/MIP-1β) for gastric problem and overall strain. In contrast, IL-6 resulted weakly associated with anxiety score as well as with the other strain dimensions. Taken together, these results pointed out a clear connection between some elements of the chemokine pattern and the features of psychophysical strain. Interestingly, BDNF was positively associates with the score of the ergonomic problems at the workplace.Fig. 2Variable Importance to the Projection (VIP) ranking biological markers for their contribution to the association to psychophysical strain, assessed by Partial Least Square (PLS) discriminant analysis. Analytes with VIP values equal or above one (dashed line as reference) are the best contributors to a given model. IL = interleukin; LIF = leukemia inhibitory factor; MIF = macrophage migration inhibitory factor; SCF = stem cell factor; TNF = tumor necrosis factor; TNFSF = tumor necrosis factor superfamily member; TRAIL = TNF-related apoptosis-inducing ligand; IFN = interferon; CSF = colony stimulating factor; GM-CSF = granulocyte macrophage colony stimulating factor; CCL = chemokine C-C motif ligand; CTACK = cutaneous T-cell-attracting chemokine; CXCL = chemokine C-X-C motif ligand; GRO = melanoma growth stimulating activity; MCP = monocyte chemoattractant protein; MIG = monokine induced by gamma interferon; SDF = stromal cell-derived factor; Eotaxin = eosinophil chemotactic protein; IP = interferon gamma-induced protein; MIP = macrophage inflammatory protein; RANTES = regulated on activation, normal T cell expressed and secreted; HGF = hepatocyte growth factor; M-CSF = macrophage colony-stimulating factor; NGF = nerve growth factor; CLEC11 = C-type lectin domain family 11; SCGF = stem cell growth factor; FGF = fibroblast growth factor; G-CSF = granulocyte-colony stimulating factor; PDGF-BB= Platelet-derived growth factor subunit B; VEGF = vascular endothelial growth factor; BDNF = brain-derived neurotrophic factor.Fig. 2

4. Discussion {#sec4}
=============

In this study, we investigated the relationship between the scores obtained from self-assessed questionnaires for the stress-risk evaluation (subjective assessments) and changes in circulating level of humoral mediators (objective measures). Serum levels of 48 chemokines, cytokines and growth factors were measured using a multiplex immunoassay, and serum brain-derived neurotrophic factor (BDNF) by ELISA. The perceived stress at work was estimated in 115 healthy hospital workers, using an instrument standardized for the Italian context, the Qu-BO test ([@bib13], [@bib22]): five subscales were administered that evaluate pshychophysical strain in term of anxiety, emotional status, gastrointestinal and cardiac disturbances, along with ergonomic problems at the workplace (headache, hurting neck or shoulders or back pain). Higher anxiety scale scores were correlated with lower serum chemokine C-C motif ligand-2 (CCL2/MCP-1), chemokine C-C motif ligand-5 (CCL5/RANTES), chemokine C-C motif ligand-27 (CCL27/CTACK), chemokine C-C motif ligand-11 (CCL11/Eotaxin) and interleukin-6 (IL-6); gastrointestinal disturbances correlated with increased levels of interleukin-17 (IL-17) and reduced CCL11/Eotaxin, CCL27/CTACK and CCL2/MCP-1; while cardiac dysfunctions associate only to reduced CCL27/CTACK, and ergonomic dysfunction correlated with increased BDNF and reduced CCL11/Eotaxin and CCL5/RANTES. We propose that these 7 serum factors may provide a distinct signature for each different stress-related psychophysical outcome giving indications on individual vulnerabilities.

Our results highlighted a significant gender difference in the perceived job-stress. This is not surprisingly, since males and females are known to differently respond to stress, both acute and chronic ([@bib38], [@bib37]). In particular, we found that women had higher scores for all the subscales of psychophysical strain. The finding that women are more susceptible to job-related psychosocial stress is in line with previous evidence showing a higher tendency for female to develop stress-related pathology such as anxiety and depression ([@bib1]). This condition is potentially due to an estrogen-driven delayed shut off of the HPA axis ([@bib30]).

The Qu-Bo Test is a self-report instrument aimed at determining perceived characteristics of the work environment (i.e., job stressors) that may elicit a stress response in the individual. Similarly, the Qu-Bo Test assesses perceived psychological and physical symptoms due to work-related stress (i.e., psychophysical strain). Other instruments, such as the V.I.S. method (see for example [@bib24]), investigate observer ratings (e.g., supervisor\'s rating) of job stressors, as well as physician\'s rating of psychophysical strain. Accordingly, the aim of this study was to investigate the association between "perceived" psychophysical strain and serum levels of possible biomarkers of work-related stress. Therefore, it is possible that female workers face higher levels of job stressors (e.g., work-family conflict) and, consequently, they experience higher levels of psychophysical strain, as we observed in this study.

Concerning BMI, we observed a negative correlation with psychophysical strain, significant for anxiety, gastric problems and overall strain, therefore, all subsequent analysis for associations with biochemical variables were conducted controlling for both gender and BMI.

After controlling for BMI and gender, we found that higher scores of each psychophysical strain subscale were associated with lower serum concentration of some member of the chemokine family, in particular CCL2/MCP-1, CCL5/RANTES, CCL27/CTACK and CCL11/Eotaxin. Since these chemokines are involved in immune cells migration and communication, our findings support the hypothesis that chronic stress induces suppression of both cellular and humoral response ([@bib48]). Interestingly, a previous study on German industrial workers showed that higher scores of effort-reward imbalance ([@bib50]) predict lower bone-marrow derived progenitor cells ([@bib26]). Other authors suggested an increased pro-inflammatory state in job-related chronic stress ([@bib3], [@bib5]). As an example, healthy school teachers with high effort--reward-imbalance and over-commitment show increased production of IL-6 and TNF-α cytokines, which are mainly classified as pro-inflammatory ([@bib5]). Significantly, they also found in agreement with our results, dampened innate immune defense in term of reduction in natural-killer (NK) cells, which are important players of the humoral immunity ([@bib5]). Chemokine C-C motif ligand 2 (CCL2/MCP-1), one of the best characterized chemokines, is able to attract monocytes and basophils but not neutrophils or eosinophils. CCL2/MCP-1 has been categorized mainly as pro-inflammatory and implicated in different stress-related pathologies characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis ([@bib2]). However, it augments monocyte anti-tumor activity and can exert also anti-inflammatory effects ([@bib16]). Our observation of reduced circulating CCL2/MCP-1 associated to anxiety and gastric problems, is apparently in contrast with a previous study on psychosocial stress in women reporting increased levels of CCL2/MCP-1, vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) in stressed workers ([@bib3]). However, the study included a heterogeneous group of long-term sick-leave subjects diagnosed for any affective or stress-related mental disorder (depression, anxiety disorder, stress disorder, burnout syndrome, exhaustion disorder). Of note, CCL2/MCP-1, as well as other chemokines, can be produced centrally by microglia and astrocytes, and also neurons, and plays important roles in both physiological and pathological brain conditions. CCL2/MCP-1 can compromise the blood-brain-barrier integrity ([@bib56]), but it also has neuroprotective effects ([@bib10]).

We observed negative associations between CCL27/CTACK and the scores of anxiety, gastric and cardiac problems as well as overall strain dimension. Chemokine C-C motif ligand 27 (CCL27/CTACK) is a chemotactic factor mediating the homing of lymphocytes to cutaneous sites. Interestingly, high anxious mice showed lowered CCL27/CTACK, associated with an increased skin cancer burden ([@bib18]). We also found negative associations between the scores of anxiety and ergonomic problems at the workplace and the chemokines CCL5/RANTES and CCL11/Eotaxin. Lower chemokine levels, including CCL2/MCP-1 and CCL11/Eotaxin, were found in cerebrospinal fluid (CSF) of suicide attempters respect to healthy controls ([@bib34]), and increased CCL5/RANTES was found in schizophrenic patients but not in major-depressive subjects ([@bib19]). Both CCL27/CTACK and CCL5/RANTES are considered mainly pro-inflammatory chemokines and are involved in the recruitment and function of eosinophils. However, at the moment, the literature concerning job-related stress is not sufficient to support or disprove our findings.

Concerning the correlation between interleukins and psychophysical strain, previous studies showed that chronic stress is associated with increased circulating levels of pro-inflammatory cytokines IL1b, IL-6, INF-γ and TNF-α ([@bib5], [@bib32], [@bib33]) but studies in work-related stress have reported conflicting results. For example, Asberg and colleagues found no association between interleukins, INF-γ, TNF-α and psychosocial stress in women ([@bib3]). Here, we found a partial negative correlation between IL-6 and anxiety scores. IL-6 acts locally to promote migration of leukocytes from the blood stream to the site of infection, but also centrally, promoting fever, appetite suppression and stimulation of HPA axis. IL-6 has a recognized activity of both promoting and inhibiting inflammation ([@bib46]). A study on a large adult cohort found that persons with a current anxiety disorder, in particular women suffering of social phobia, had lower levels of IL-6 ([@bib55]). Interestingly, although IL-6 is predominantly classified as a pro-inflammatory cytokine, it can also trigger anti-inflammatory properties through the so-called 'classical IL-6 signaling' occurring on a subset of T cells, hepatocytes, megakaryocytes, neutrophils and monocytes through activation of the IL-6 receptor and the gp130 signal transducer ([@bib33]). Thus, a reduction in classical IL-6 signaling may be involved in reduced immune response, in agreement with our findings for chemokines.

Intriguingly, we found increased interleukin 17 (IL-17) in subjects reporting gastric problems. IL-17 is a feature cytokine of the T-helper 17, which are important players in the Th1/Th2 balance regulation and have a role in autoimmunity disease. IL-17 is associated with tissue damage in brain, joints, heart, lungs and intestines in experimental models ([@bib52]). Alterations in Th17 function have been suggested also for depressive disorders ([@bib6], [@bib47]). Interestingly, in a model of chronic psychosocial stress, stressed mice developed spontaneous colitis and gut inflammation and the effects were mediated by Th17 activity and increased IL-17 levels ([@bib47]).

In our previous study ([@bib28]) we reported that IL-12, a pro-inflammatory cytokine implicated in cellular immunity, was positively associated with interpersonal conflict at work (ICW) while we did not find here a significant association with psychosocial stress. Other studies have previously found opposite results for IL-12 in rats, leaving unresolved the issue of regulation of this interleukin in stress. According to transactional models of stress, the relationship between stressors and chronic mental and physical strain is still mediated by coping ([@bib15]), so this leaves room for possible different results between studies. Of note, both this and our previous study are cross-sectional, so it is difficult to know whether the stressor comes before the strain or *vice versa* and which are the corresponding levels of the different serum factors analyzed. Although, the results of IL-17 obtained here are quite in line with those of Girardi and colleagues, the dimensions investigated in the two studies are quite different, which leaves room for differences in results obtained.

In this study, we observed a positive association between serum BDNF and the score of ergonomic problems at workplace. A previous study on Japanese subjects with job-related stress pointed out a reduction trend in circulating BDNF ([@bib39]). Differently, another study found that chronically perceived stress increases serum BDNF levels ([@bib25]). Of note, BDNF levels are highly dynamic in response to stress and also vary across different brain regions ([@bib31]); for example, during chronic stress, increased BDNF levels have been found in amygdala while reduction has been described in prefrontal cortex and hippocampus ([@bib12]). Our findings are in agreement with a previous study showing that patients with chronic musculoskeletal pain associated with Myofascial Pain Syndrome or Fibromyalgia presented increased serum BDNF levels ([@bib8]). Intriguingly, in these patients, increased serum BDNF levels correlated with higher motor cortex excitability, possibly leading to a disinhibition in the activity of the motor cortex and the descending pain inhibitory system ([@bib8]). Our results represent a first indication that a similar mechanism may operate also in chronic job-related stress.

We ought to underline some intrinsic limitations of this study such as: 1) the study design involved only one single time point, thus the results may suffer for time course variations. 2) Scores of work-related stress resulted to be positive skewed, meaning our study population have mild to low chronic stress; therefore results need to be replicated in a more stressed population. 3) The sample size was relatively small compared to the number of serum factors considered, thus increasing the possibility of over-fitting problems. 4) We did not control for other primary mediators such as metabolic indicators (blood pressure, cholesterol) or urinary excretion of cortisol, adrenaline and noradrenaline, thus limiting the possibility to identify an allostatic load index. 5) Lastly, we did not check for historical and socio-economical statuses which are confounders that potentially influence the response to stress; however, our population was relatively homogenous in that sense, since was extracted from the same environment. In addition, immune alterations are hard to predict given the enhancing versus suppressive effects of stress on immune function ([@bib17]). Replications with larger samples, possibly on a longitudinal study analyzing the effect of interventions to reduce stressing situations at work may resolve these limitations. Nevertheless, we believe our study adds some valuable insight in immune mediator changes occurring in conditions of work-related chronic stress.

4.1. Conclusions {#sec4.1}
----------------

The seven serum factors CCL27/CTACK, CCL11/Eotaxin, CCL2/MCP-1, CCL5/RANTES, IL-17, IL-6 and BDNF that we found associated in a specific combination to the different psychophysical outcomes in work--related chronic stress, are new potential objective indicators to be coupled with the subjective assessments of psychophysical strain. As evidenced in this discussion, these seven factors are not part of a single stress-related mechanism, but are rather associated to different psychological and physical outcomes of stress, and therefore are likely to reflect different pathological mechanisms. Our results suggest reduced immune defence as a potential hallmark of mild job-related stress. Moreover, given that the pathological response to chronic stressful conditions is largely linked to individual characteristics, the possibility to have a distinct signature for the different stress-related psychophysical outcomes may provide a valuable tool to identify individual vulnerabilities in different body districts and prevent the development of more severe diseases.
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[^1]: Biochemical analytes listed by cytokines, chemokines and growth factors. IL = interleukin; LIF = leukemia inhibitory factor; MIF = macrophage migration inhibitory factor; SCF = stem cell factor; TNF = tumor necrosis factor; TNFSF = tumor necrosis factor superfamily member; TRAIL = TNF-related apoptosis-inducing ligand; IFN = interferon; CSF = colony stimulating factor; GM-CSF = granulocyte macrophage colony stimulating factor; CCL = chemokine C-C motif ligand; CTACK = cutaneous T-cell-attracting chemokine; CXCL = chemokine C-X-C motif ligand; GRO = melanoma growth stimulating activity; MCP = monocyte chemoattractant protein; MIG = monokine induced by gamma interferon; SDF = stromal cell-derived factor; Eotaxin = eosinophil chemotactic protein; IP = interferon gamma-induced protein; MIP = macrophage inflammatory protein; RANTES = regulated on activation, normal T cell expressed and secreted; HGF = hepatocyte growth factor; M-CSF = macrophage colony-stimulating factor; NGF = nerve growth factor; CLEC11 = C-type lectin domain family 11; SCGF = stem cell growth factor; FGF = fibroblast growth factor; G-CSF = granulocyte-colony stimulating factor; PDGF-BB= Platelet-derived growth factor subunit B; VEGF = vascular endothelial growth factor; BDNF = brain-derived neurotrophic factor.

[^2]: Age and BMI distributions split by gender. Number of subjects (N), average values (mean), standard deviations (SD) and minimum and maximum values (min/max) are given, along with P values (P) as the result of distribution comparison between male and female, for both age and BMI. Upper table displays whole population (N = 115); lower table the drug-free sample population (N = 89).

[^3]: Scores distribution of psychophysical strain in the whole sample population (N = 115) and after exclusion of pharmaceutical drug users and subjects missing strain scores (N = 89).

[^4]: Results of comparison (Mann-Whitney *U* test) between female and male scores of psychophysical strain in the total sample population (N = 115) and after exclusion of pharmaceutical drug users and subjects missing the strain scores (N = 89). Sizes, (N), rank values, Z scores and asymptotic P values (Asymp. Sig. P, 2-tailed) are given. In bold are highlighted P \< 0.05.

[^5]: Summary of the significant results from partial correlation analysis, controlling for gender and BMI, between biological variables (independent variables, first column) and scores of psychophysical strain (first row). Correlation values (minus sign indicate a negative correlation) and P values in brackets, highlighted in bold, are given. CCL = chemokine C-C motif ligand; CTACK = cutaneous T-cell-attracting chemokine; MCP = monocyte chemoattractant protein; RANTES = regulated on activation, normal T cell expressed and secreted; BDNF = brain-derived neurotrophic factor; IL = interleukin.
